Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today
GAINERS:
Mind Medicine (NASDAQ:MNMD) shares closed up 25.48% at $1.17
Psychedelic Stock Gainers And Losers From January 24, 2022
GAINERS:
Field Trip Health (NASDAQ:FTRP) shares closed up 6.45% at $1.98
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
GAINERS:
Revive Therapeutics (OTC:RVVTF) shares closed up 14.94% at $0.25
Psychedelic Stock Gainers And Losers From January 18, 2022
GAINERS:
Cybin (AMEX:CYBN) shares closed up 1.90% at $1.07
46 Biggest Movers From Yesterday
Gainers
Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.
36 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal emergency response systems to Federal, State and Local government purchasers.
Psilera’s DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
Psilera is a Florida-based biotechnology company focused on developing drugs to treat mental disorders using non-hallucinogenic derivatives from psychedelic compounds. The company is aiming to alleviate adverse effects of disorders such as anxiety, addiction and PTSD.
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis by partnering with neuroscience company Delix Therapeutics to study a non-hallucinogenic version of the psychedelic drug ibogaine.
New York’s Horizons Psychedelic Conference Highlights Big Donations In The Growing Industry
Venture capitalist and businessman Stephen Jurvetson is joining an expanding group of prominent investors who are backing research into psychedelic ventures.